ArticleMolecular genetics & genomic medicine2025
Molecular Analysis of the HGD Gene in 9 Families With Alkaptonuric Ochronosis in Iran and Identification of Two Novel Variants.
Article in Molecular genetics & genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Analysis of the HGD Gene in 9 Families With Alkaptonuric Ochronosis in Iran and Identification of Two Novel Variants.Molecular genetics & genomic medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAlkaptonuria (AKU) (MIM number 203500) or homogentisic acid oxidase deficiency is a metabolic autosomal recessive disorder caused by mutations in the homogentisate 1, 2-dioxygenase (HGD) (MIM number 607474) gene. The HGD is located on chromosome 3q13 with 14 exons, and encodes the homogentisate 1, 2-dioxygenase enzyme, which is composed of 445 amino acids. Although AKU was first described more than 120 years ago, we lack studies investigating its mutational spectrum in Iran. MATERIALS AND
resultsThis study aimed to investigate the spectrum of homogenetic gene mutations in patients diagnosed with Ochronosis Alkaptonuria in Ardabil, Iran. To achieve this, all individuals affected by this disease, totaling 23 individuals, whose affliction with Ochronosis Alkaptonuria had previously been definitively confirmed, were enrolled in the study. Sanger sequencing identified five unique variants in the HGD gene (NM_000187.4), all of which were homozygous variants. Two of the variants (c.113delA and c.342+5G>A) were novel and have not been reported in variant databases, including gnomAD, ClinVar, and HGMD. Other identified variants were c.175delA, c.334T>G, and c.680T>C, which have been previously reported in variant databases.
conclusionIn this study, the mutational spectrum of alkaptonuric ochronosis was investigated in Iran. The HGD gene is a well-studied gene, and hundreds of variants responsible for alkaptonuria have been reported to date. However, we found two novel variants that have not been reported in previous studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.